Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

Clinical trial NCT00210301 · UNKNOWN

Trial details

NCT number: NCT00210301
Sponsor: Institute for Clinical Research
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2003-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.